EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Brain Atrophy Does Not Predict Clinical Progression in Progressive Supranuclear Palsy

Andrea Quattrone iD, Nicolai Franzmeier, Hans-Jürgen Huppertz, Nicholas Seneca, Gabor C Petzold, Annika Spottke, Johannes Levin, Johannes Prudlo, Emrah Düzel, PASSPORT Study Group, the AL‐108‐231 Investigators, the Arise Investigators, the Tauros MRI Investigators, the DESCRIBE‐PSP group, Günter U Höglinger

Movement Disorders · 2025

DOI: 10.1002/mds.70026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Movement Disorders, 2025. Verfasst von Andrea Quattrone und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University Hospital, LMU Munich, Munich, Germany. Hauptthemen laut MEDLINE: Brain, Supranuclear Palsy, Progressive. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Clinical progression rate is the typical primary endpoint measure in progressive supranuclear palsy (PSP) clinical trials.

Objectives

This longitudinal multicohort study investigated whether baseline clinical severity and regional brain atrophy could predict clinical progression in PSP–Richardson's syndrome (PSP‐RS).

Methods

PSP‐RS patients (n = 309) from the placebo arms of clinical trials (NCT03068468, NCT01110720, NCT02985879, NCT01049399) and DescribePSP cohort were included. We investigated associations of baseline clinical and volumetric magnetic resonance imaging (MRI) data with 1‐year longitudinal PSP rating scale (PSPRS) change. Machine learning (ML) models were tested to predict individual clinical trajectories.

Results

PSP‐RS patients showed a mean PSPRS score increase of 10.3 points/yr. The frontal lobe volume showed the strongest association with subsequent clinical progression (β: −0.34, P < 0.001). However, ML models did not accurately predict individual progression rates ( R 2

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BrainSupranuclear Palsy, ProgressiveAgedFemaleHumansMaleMiddle AgedAtrophyDisease ProgressionLongitudinal StudiesMachine LearningMagnetic Resonance ImagingSeverity of Illness IndexRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

atlas‐based volumetryclinical trialsoutcomeprogressionprogressive supranuclear palsy

Autor:innen und Institutionen

  • Department of Neurology, University Hospital, LMU Munich, Munich, Germany.
  • Institute of Neurology, Department of Medical and Surgical Sciences, Magna Graecia University, Catanzaro, Italy.
  • Neuroscience Research Centre, Magna Graecia University, Catanzaro, Italy.
  • Institute for Stroke and Dementia Research (ISD), University Hospital, LMU, Munich, Germany.
  • Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
  • Department of Psychiatry and Neurochemistry, University of Gothenburg, The Sahlgrenska Academy, Institute of Neuroscience and Physiology, Mölndal and Gothenburg, Sweden.

ORCID-Profile: Andrea Quattrone

Zitieren

APA

Quattrone, A., Franzmeier, N., Huppertz, H. J., Seneca, N., Petzold, G. C., Spottke, A., Levin, J., Prudlo, J., Düzel, E., PASSPORT Study Group, the AL‐108‐231 Investigators, the Arise Investigators, the Tauros MRI Investigators, the DESCRIBE‐PSP group, & Höglinger, G. U. (2025). Brain Atrophy Does Not Predict Clinical Progression in Progressive Supranuclear Palsy. Movement Disorders. https://doi.org/10.1002/mds.70026

Vancouver

Quattrone A, Franzmeier N, Huppertz HJ, Seneca N, Petzold GC, Spottke A, et al. Brain Atrophy Does Not Predict Clinical Progression in Progressive Supranuclear Palsy. Movement Disorders. 2025. doi:10.1002/mds.70026

BibTeX
@article{Quattrone2025,
  author = {Quattrone, Andrea and Franzmeier, Nicolai and Huppertz, Hans-Jürgen and Seneca, Nicholas and Petzold, Gabor C and Spottke, Annika and Levin, Johannes and Prudlo, Johannes and Düzel, Emrah and PASSPORT Study Group, the AL‐108‐231 Investigators, the Arise Investigators, the Tauros MRI Investigators, the DESCRIBE‐PSP group, PASSPORT Study Group, the AL‐108‐231 Investigators, the Arise Investigators, the Tauros MRI Investigators, the DESCRIBE‐PSP group and Höglinger, Günter U},
  title = {Brain Atrophy Does Not Predict Clinical Progression in Progressive Supranuclear Palsy},
  journal = {Movement Disorders},
  year = {2025},
  doi = {10.1002/mds.70026}
}
Kostenlos starten →